mannitol has been researched along with Lymphoma in 23 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 12 (52.17) | 18.7374 |
1990's | 2 (8.70) | 18.2507 |
2000's | 6 (26.09) | 29.6817 |
2010's | 3 (13.04) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alahuhta, S; Isokangas, M; Keinänen, T; Kiviniemi, V; Korhonen, V; Kortelainen, J; Kuittinen, O; Myllylä, T; Nikkinen, J; Rytky, S; Siniluoto, T; Sonkajärvi, E; Tervonen, O; Tuovinen, T; Turpeenniemi-Hujanen, T; Voipio, J | 1 |
Alahuhta, S; Isokangas, M; Kuittinen, O; Peltonen, J; Siniluoto, T; Sonkajärvi, E; Turpeenniemi-Hujanen, T | 1 |
Bortner, CD; Cidlowski, JA; Scoltock, AB; Sifre, MI | 1 |
Barnett, G; Cucullo, L; Fazio, V; Janigro, D; Kight, K; Kinter, M; Marchi, N; Masaryk, T; Mayberg, MR; Rasmussen, P; Vogelbaum, M; Volgelbaum, M | 1 |
GRAF, F; TAKACS NAGY, L | 1 |
GRAF, F; TAKACSI NAGY, L | 1 |
GRIZZLE, J; JONSSON, U; LASZLO, J; RUNDLES, RW | 1 |
COOK, GT | 1 |
Angelov, L; Diglaw, T; Fazio, V; Franic, L; Granata, T; Hallene, K; Hernandez, N; Janigro, D; Marchi, N; Masaryk, T; Najm, I | 1 |
Ference, SJ; Galor, A; Lee, MS; Peereboom, DM; Perez, VL; Singh, AD; Stevens, GH | 1 |
Goldstein, DA; Tessler, HH | 1 |
Frenkel, EP; Hill, SA; Neuwelt, EA | 1 |
Fishburne, BC; Neuwelt, EA; Rosenbaum, JT; Wilson, DJ | 1 |
Bokstein, F; Chisin, R; Gomori, JM; Lossos, A; Rubinstein, R; Schwartz, A; Shalom, E; Siegal, T | 1 |
Apollo, D; Barnett, G; Janigro, D; Kapural, M; Krizanac-Bengez, Lj; Masaryk, T; Mayberg, MR; Perl, J; Rasmussen, P | 1 |
Coccia, PF; Kjellstrand, CM; Lynch, RE | 1 |
Cvitkovic, E; Gonzales-Vitale, JC; Hayes, DM; Sternberg, SS | 1 |
Thumb, N | 1 |
Martin, JB; Riskind, PN | 1 |
Benedeczky, I; Jeney, A; Kopper, L; Lapis, K; Szende, B | 1 |
Pochedly, C | 1 |
Gál, F; Hercsei, I; Institóris, L; Kellner, B; Németh, L; Somfai, S; Zaka, S | 1 |
Hamburger, JI | 1 |
2 review(s) available for mannitol and Lymphoma
Article | Year |
---|---|
[Chemotherapy in conjunction with blood brain barrier disruption in the treatment of primary central nervous system lymphoma].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Blood-Brain Barrier; Central Nervous System Neoplasms; Humans; Lymphoma; Mannitol | 2013 |
Renal and metabolic complications of childhood non-Hodgkin's lymphoma.
Topics: Acidosis; Acute Kidney Injury; Allopurinol; Aluminum Hydroxide; Burkitt Lymphoma; Child; Humans; Hypercalcemia; Hyperlipidemias; Hypertension, Renal; Hypoglycemia; Lymphoma; Male; Mannitol; Metabolic Diseases; Phosphorus Metabolism Disorders; Uric Acid; Xanthines | 1977 |
1 trial(s) available for mannitol and Lymphoma
Article | Year |
---|---|
Serum transthyretin monomer as a possible marker of blood-to-CSF barrier disruption.
Topics: Biomarkers; Blood Proteins; Blood-Brain Barrier; Blotting, Western; Brain; Brain Neoplasms; Cerebrospinal Fluid Proteins; Electrophoresis, Gel, Two-Dimensional; Haptoglobins; Humans; Infusions, Intra-Arterial; Lymphoma; Mannitol; Methotrexate; Nerve Growth Factors; Phosphopyruvate Hydratase; Prealbumin; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tomography, X-Ray Computed | 2003 |
20 other study(ies) available for mannitol and Lymphoma
Article | Year |
---|---|
Real-time monitoring of human blood-brain barrier disruption.
Topics: Adult; Aged; Anesthesia; Antineoplastic Agents; Blood-Brain Barrier; Capillary Permeability; Carotid Arteries; Central Nervous System Neoplasms; Electroencephalography; Female; Hemoglobins; Humans; Infusions, Intra-Arterial; Lymphoma; Male; Mannitol; Middle Aged; Neurophysiological Monitoring; Oxyhemoglobins; Spectroscopy, Near-Infrared; Vertebral Artery; Young Adult | 2017 |
Osmotic stress resistance imparts acquired anti-apoptotic mechanisms in lymphocytes.
Topics: Animals; Apoptosis; Caspases; Cell Line, Tumor; Cell Size; Culture Media; Diuretics, Osmotic; Flow Cytometry; Homeostasis; Lymphoma; Mannitol; Mice; Osmotic Pressure; Signal Transduction; Stress, Physiological; T-Lymphocytes | 2012 |
THE THERAPEUTIC VALUE OF 1,6-BIS-(BETA-MESYLOXYETHYLAMINO)-1,6-DIDESOXY-D-MANNITE DICHLORHYDRATE IN CLINICAL PRACTICE.
Topics: Antineoplastic Agents; Blood Platelets; Erythrocyte Count; Hodgkin Disease; Humans; Leukemia; Leukemia, Lymphoid; Leukocyte Count; Lymph Nodes; Lymphocytes; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Mannitol; Neoplasms; Radiography, Thoracic; Sarcoma | 1964 |
[CLINICAL TESTING OF THE THERAPEUTIC EFFECT OF 1,6-BIS(2-MESYLOXYETHYLAMINO) 1,6-DIDESOXY-D-MANNITOL DI-HC1 (R 49)].
Topics: Antineoplastic Agents; Blood Cell Count; Blood Platelets; Hodgkin Disease; Leukemia; Leukemia, Lymphoid; Leukopenia; Lymphadenitis; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Mannitol; Mannomustine; Neoplasms; Radiography, Thoracic; Sarcoma; Thrombocytopenia; Toxicology | 1964 |
Comparative study of mannitol mustard, cyclophosphamide, and nitrogen mustard in malignant lymphomas.
Topics: Antineoplastic Agents; Cyclophosphamide; Lymphoma; Mannitol; Mannomustine; Mechlorethamine; Nitrogen Mustard Compounds | 1962 |
A late mannitol-fermenting strain and rapidly fermenting variant of Shigella Flexneri type Z.
Topics: Lymphoma; Lymphoma, Non-Hodgkin; Mannitol; Shigella; Shigella flexneri | 1951 |
Seizure-promoting effect of blood-brain barrier disruption.
Topics: Adult; Animals; Antineoplastic Agents; Biomarkers; Blood-Brain Barrier; Brain; Brain Neoplasms; Cerebrovascular Disorders; Disease Models, Animal; Electroencephalography; Female; Functional Laterality; Humans; Infusions, Intra-Arterial; Lymphoma; Male; Mannitol; Methotrexate; Middle Aged; Osmotic Pressure; S100 Proteins; Seizures; Swine; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
Maculopathy as a complication of blood-brain barrier disruption in patients with central nervous system lymphoma.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Brain Neoplasms; Carotid Artery, Internal; Catheterization, Peripheral; Cyclophosphamide; Cytarabine; Etoposide; Female; Fluorescein Angiography; Humans; Injections, Spinal; Lymphoma; Male; Mannitol; Methotrexate; Middle Aged; Pigment Epithelium of Eye; Retinal Diseases; Retrospective Studies; Tomography, Optical Coherence; Vertebral Artery | 2007 |
Re: Maculopathy as a complication of blood-brain barrier disruption in patients with central nervous system lymphoma.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Brain Neoplasms; Cyclophosphamide; Cytarabine; Etoposide; Fluorescein Angiography; Humans; Injections, Spinal; Lymphoma; Mannitol; Methotrexate; Pigment Epithelium of Eye; Retinal Diseases | 2007 |
Osmotic blood-brain barrier modification and combination chemotherapy: concurrent tumor regression in areas of barrier opening and progression in brain regions distant to barrier opening.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Brain Neoplasms; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Combined Modality Therapy; Cyclophosphamide; Female; Glioma; Humans; Leucovorin; Lymphoma; Male; Mannitol; Methotrexate; Procarbazine; Tomography, X-Ray Computed; Water-Electrolyte Balance | 1984 |
Intravitreal methotrexate as an adjunctive treatment of intraocular lymphoma.
Topics: Aged; Antimetabolites, Antineoplastic; Blood-Brain Barrier; Central Nervous System Neoplasms; Chemotherapy, Adjuvant; Diuretics, Osmotic; Eye Neoplasms; Female; Humans; Injections; Lymphoma; Male; Mannitol; Methotrexate; Middle Aged; Radiotherapy, Adjuvant; Survival Rate; Visual Acuity; Vitreous Body | 1997 |
In vivo assessment of the window of barrier opening after osmotic blood-brain barrier disruption in humans.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Brain; Brain Neoplasms; Contrast Media; Diuretics, Osmotic; Female; Humans; Infusions, Intra-Arterial; Lymphoma; Male; Mannitol; Middle Aged; Molecular Weight; Neuroectodermal Tumors; Organotechnetium Compounds; Osmosis; Permeability; Radiopharmaceuticals; Sugar Acids; Time Factors; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2000 |
Serum S-100beta as a possible marker of blood-brain barrier disruption.
Topics: Biomarkers; Blood-Brain Barrier; Central Nervous System Neoplasms; Drug Administration Schedule; Humans; Infusions, Intra-Arterial; Lymphoma; Mannitol; Nerve Growth Factors; Phosphopyruvate Hydratase; Predictive Value of Tests; S100 Calcium Binding Protein beta Subunit; S100 Proteins | 2002 |
The renal pathology in clinical trials of cis-platinum (II) diamminedichloride.
Topics: Acute Kidney Injury; Adult; Aged; Blood Urea Nitrogen; Cisplatin; Creatinine; Drug Evaluation; Epithelium; Female; Humans; Kidney; Kidney Tubular Necrosis, Acute; Kidney Tubules, Distal; Lymphoma; Male; Mannitol; Middle Aged; Neoplasms | 1977 |
[Side effects in immunosuppressive therapy].
Topics: Alopecia; Amenorrhea; Anemia; Azathioprine; Bacterial Infections; Chlorambucil; Female; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Leukemia; Lymphoma; Male; Mannitol; Mycoses; Procarbazine; Skin Neoplasms; Spermatogenesis; Virus Diseases | 1975 |
Neurologic manifestations of hypothalamic disease.
Topics: Adult; Aged; Bromocriptine; Female; Humans; Hypothalamic Neoplasms; Lymphoma; Magnetic Resonance Imaging; Male; Mannitol; Methotrexate; Middle Aged; Prednisone; Radiotherapy Dosage; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1992 |
Cell population kinetics, biochemical, ultrastructural changes occurring during growth of experimental tumors and their relevance to cancer chemotherapy.
Topics: Animals; Antineoplastic Agents; Cell Division; DNA, Neoplasm; Lymphoma; Mannitol; Methods; Microscopy, Electron; Neoplasms, Experimental | 1973 |
Hyperuricemia in leukemia and lymphoma.
Topics: Acetazolamide; Acute Kidney Injury; Allopurinol; Antineoplastic Agents; Bicarbonates; Crystallization; Disease Susceptibility; Diuretics, Osmotic; Humans; Hydrogen-Ion Concentration; Infusions, Parenteral; Leukemia; Lymphoma; Mannitol; Peritoneal Dialysis; Radiotherapy; Renal Dialysis; Uric Acid | 1974 |
Investigation into the correlation of cytostatic activity with the in vitro diepoxide formation on some terminally substituted hexitols.
Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Chemistry, Pharmaceutical; Chromatography, Thin Layer; Ethers, Cyclic; Hexoses; Hydrocarbons; Hydrocarbons, Halogenated; Injections, Intraperitoneal; Leukemia, Experimental; Lymphoma; Mannitol; Mice; Neoplasms, Experimental; Rats | 1970 |
Experience with thyroid malignancy in a private referral laboratory.
Topics: Adenoma; Adolescent; Adult; Aged; Carcinoma; Child; Ethacrynic Acid; Female; Humans; Iodine; Iodine Isotopes; Lymphoma; Male; Mannitol; Middle Aged; Neoplasm Metastasis; Referral and Consultation; Thyroid Neoplasms; Thyroidectomy; Thyrotropin | 1969 |